Clinical Trial Update: Evaluation of Immune Response Against the Strain of Neisseria Meningitidis B: 14, P1-7, 16 in Patients Having to be Vaccinated MenBVac® (Extension EFFIVAC)

View source ↗

Summary

A completed clinical trial update evaluating the immune response to a Neisseria meningitidis B strain in participants vaccinated with MenBVac (Extension EFFIVAC…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• MenBVac (Meningococcal B vaccine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Neisseria Meningitidis | Status: COMPLETED